Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia

MeSH terms

• Adenine / analogs & derivatives
• Agammaglobulinaemia Tyrosine Kinase
• Antineoplastic Agents / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Fever / etiology
• Fever / prevention & control
• Fusariosis / complications*
• Fusariosis / immunology
• Fusariosis / microbiology
• Fusariosis / physiopathology
• Fusarium / drug effects
• Fusarium / immunology
• Fusarium / isolation & purification
• Humans
• Immunocompromised Host
• Leukemia, Lymphocytic, Chronic, B-Cell / complications
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
• Leukemia, Lymphocytic, Chronic, B-Cell / immunology
• Leukemia, Lymphocytic, Chronic, B-Cell / physiopathology
• Lymphadenopathy / etiology
• Lymphadenopathy / prevention & control
• Maintenance Chemotherapy
• Male
• Middle Aged
• Neoplasm Recurrence, Local / complications
• Neoplasm Recurrence, Local / drug therapy
• Neoplasm Recurrence, Local / immunology
• Opportunistic Infections / complications*
• Opportunistic Infections / immunology
• Opportunistic Infections / microbiology
• Opportunistic Infections / physiopathology
• Piperidines
• Protein Kinase Inhibitors / therapeutic use*
• Protein-Tyrosine Kinases / antagonists & inhibitors*
• Protein-Tyrosine Kinases / metabolism
• Pyrazoles / therapeutic use*
• Pyrimidines / therapeutic use*
• Remission Induction
• Treatment Outcome